Summary
- Current Price
- As of today, AUPH price is $14.41, up +0.07% in the most recent trading session on
- Current Price All-Time High
- AUPH price is currently -57.58% below its historical high of $33.97 set on
- Market Cap
- AUPH current market cap is $2B, up +72.22% over the past 365 days
- PE Ratio
- AUPH current PE ratio is 25.68
- Revenue
- AUPH current annual revenue is $235.13M, up +33.97% year-over-year
- Next Earnings
- The next earnings release for AUPH is on
Profile
| Metric | Value |
|---|---|
| Full Name | Aurinia Pharmaceuticals Inc. |
| Ticker | NASDAQ: AUPH |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Canada |
| IPO | |
| Indexes | Not included |
| Website | auriniapharma.com |
| Employees | 130 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $14.41 | |
| Price, 1D Change | +0.07% | |
| $2B | ||
| - | ||
| 25.68 | ||
| 0.68 | ||
| $235M | ||
| Revenue, 1Y Change | +33.97% | |
| $0.04 | ||
| EPS, 1Y Change | +107.21% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:50 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.04 | ||
| EPS Estimate | $0.78 | |
| EPS Est. Change | +1,889.06% | |
| $235.13M | ||
| Revenue Estimate | $280.63M | |
| Revenue Est. Change | +19.35% | |
| Current Price | $14.41 | |
| Price Target | - | $16.50 |
| Price Tgt. Change | - | +14.50% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.52 | -$0.54 | -4.75% | |
| $0.03 | $0.04 | +51.15% | |
| $0.78 | N/A | +1,889.06% | |
| $0.93 | N/A | +2,253.69% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $174.84M | $175.51M | +0.38% | |
| $235.68M | $235.13M | -0.23% | |
| $280.63M | N/A | +19.35% | |
| $327.10M | N/A | +39.11% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $14.41 | |
| $12.06 | ||
| SMA 200 vs Price | -16.34% | |
| $15.18 | ||
| SMA 50 vs Price | +5.37% | |
| 0.68 | ||
| $0.42 | ||
| 43.16 | ||
| 16.49% | ||
| 45.40% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $235.13M | ||
| $0.04 | ||
| $206.89M | ||
| 87.99% | ||
| $14.07M | ||
| 5.98% | ||
| $5.75M | ||
| 2.45% | ||
| $33.52M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.21 | ||
| 4.57 | ||
| 4.17 | ||
| - | ||
| 8 | ||
| 5.47 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 25.68 | ||
| 7.15 | ||
| 5.19 | ||
| 13.95 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $377.48M | ||
| $358.48M | ||
| $550.65M | ||
| $446.60M | ||
| $173.17M | ||
| $97.76M | ||
| $79.37M | ||
| $15.07M | ||
| $5.19M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $229.38M | ||
| $192.81M | ||
| $28.25M | ||
| $0.00 | ||
| $19.45M | ||
| $0.00 | ||
| $1.70M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $44.39M | ||
| $39.26M | ||
| -$49.09M | ||
| $281.00K | ||
| $44.11M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Leerink Partners | → | |
| Jefferies | → | |
| RBC Capital | → | |
| RBC Capital | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with AUPH
FAQ
What is the ticker symbol for Aurinia Pharmaceuticals Inc.?
The ticker symbol for Aurinia Pharmaceuticals Inc. is NASDAQ:AUPH
Does Aurinia Pharmaceuticals Inc. pay dividends?
No, Aurinia Pharmaceuticals Inc. does not pay dividends
What sector is Aurinia Pharmaceuticals Inc. in?
Aurinia Pharmaceuticals Inc. is in the Healthcare sector
What industry is Aurinia Pharmaceuticals Inc. in?
Aurinia Pharmaceuticals Inc. is in the Biotechnology industry
What country is Aurinia Pharmaceuticals Inc. based in?
Aurinia Pharmaceuticals Inc. is headquartered in Canada
When did Aurinia Pharmaceuticals Inc. go public?
Aurinia Pharmaceuticals Inc. initial public offering (IPO) was on September 3, 2014
Is Aurinia Pharmaceuticals Inc. in the S&P 500?
No, Aurinia Pharmaceuticals Inc. is not included in the S&P 500 index
Is Aurinia Pharmaceuticals Inc. in the NASDAQ 100?
No, Aurinia Pharmaceuticals Inc. is not included in the NASDAQ 100 index
Is Aurinia Pharmaceuticals Inc. in the Dow Jones?
No, Aurinia Pharmaceuticals Inc. is not included in the Dow Jones index
When was Aurinia Pharmaceuticals Inc. last earnings report?
Aurinia Pharmaceuticals Inc.'s most recent earnings report was on November 4, 2025
When does Aurinia Pharmaceuticals Inc. report earnings?
The next expected earnings date for Aurinia Pharmaceuticals Inc. is February 26, 2026
Data Sources & References
- AUPH Official Website www.auriniapharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1600620/000160062025000106/0001600620-25-000106-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1600620/000160062025000011/0001600620-25-000011-index.htm
- AUPH Profile on Yahoo Finance finance.yahoo.com/quote/AUPH
- AUPH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/auph